btw I mentioned I've completed 72 Irish stock valuations, but I'll continue to include
AGI Therapeutics (which was taken over) as a 73rd stock for performance purposes.
With
AGI Therapeutics (AGI: ID / LN), however, I essentially faced no FX risk on the deal in the end.
OK, we've run through the key components of
the AGI Therapeutics (AGI: ID / LN) offer.
Yes,
AGI Therapeutics (AGI: ID / LN) was the Risk Arb investment to which I was referring.